학술논문
Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study
Document Type
Article
Author
Berger, Michael; Bromberg, Jacqueline; Chen, Linda; Dang, Chau; Das, Jeeban P; Drullinsky, Pamela; Eng, Julianna; Flynn, Jessica; Gelblum, Daphna Y; Gillespie, Erin F; Girshman, Jeffrey; Gomez, Daniel R; Gucalp, Ayca; Guttmann, David; Hajj, Carla; Higginson, Daniel; Iqbal, Afsheen; Khan, Atif J; LaPlant, Quincey; Lee, Nancy Y; Mann, Justin M; Modi, Shanu; Namakydoust, Azadeh; Ng, Kenneth; Patel, Juber; Powell, Simon N; Preeshagul, Isabel; Reis-Filho, Jorge S; Reyngold, Marsha; Riaz, Nadeem; Rimner, Andreas; Robson, Mark E; Rudin, Charles M; Sanford, Rachel; Seidman, Andrew D; Shah, Ronak; Shaverdian, Narek; Shepherd, Annemarie F; Shin, Jacob Y; Sugarman, Steven; Traina, Tiffany A; Tsai, Chiaojung Jillian; Wu, Abraham J; Xu, Amy J; Yang, Jonathan T; Yeh, Randy; Zhang, Zhigang; Zhi, Wanqing; Eng, Juliana; Seidman, Andrew; Traina, Tiffany
Source
In The Lancet 13-19 January 2024 403(10422):171-182
Subject
Language
ISSN
0140-6736